New diabetes monitor put to the test
NCT ID NCT07296276
Summary
This study is testing how well a new continuous glucose monitor (CGM) called CareSens Air 3 measures blood sugar levels in adults with type 1 diabetes. Participants will wear the new device and a comparison device for 16 days while checking their blood sugar with fingersticks. The main goal is to see how closely the monitor's readings match precise lab measurements taken during clinic visits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlanta Diabetes Associates
NOT_YET_RECRUITINGAtlanta, Georgia, 30318, United States
Contact Phone: •••-•••-••••
-
Diablo Clinical Research
RECRUITINGWalnut Creek, California, 94598, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Headlands Research AMCR
NOT_YET_RECRUITINGEscondido, California, 92025, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rainier Clinical Reseach Center
RECRUITINGRenton, Washington, 98057, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.